Camp4 Therapeutics Corp - CAMP

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G Balyasny Asset Management L.P. 5.07% 2,632,437 View
May 15, 2026 SCHEDULE 13G BAM GP LLC 5.07% 2,632,437 View
May 15, 2026 SCHEDULE 13G Balyasny Asset Management Holdings LP 5.07% 2,632,437 View
May 15, 2026 SCHEDULE 13G Dames GP LLC 5.07% 2,632,437 View
May 15, 2026 SCHEDULE 13G Dmitry Balyasny 5.07% 2,632,437 View
Mar 11, 2026 SCHEDULE 13D/A — — — View
Feb 13, 2026 SCHEDULE 13G/A Vivo Opportunity Fund Holdings, L.P. 7.4% 3,856,991 View
Feb 13, 2026 SCHEDULE 13G/A Vivo Opportunity, LLC 7.4% 3,856,991 View
Feb 13, 2026 SCHEDULE 13G/A Vivo Opportunity Cayman Fund, L.P. 0.8% 389,577 View
Feb 13, 2026 SCHEDULE 13G/A Vivo Opportunity Cayman, LLC 0.8% 389,577 View
Feb 05, 2026 SCHEDULE 13G/A FMR LLC 9.5% 4,918,243 View
Feb 05, 2026 SCHEDULE 13G/A Abigail P. Johnson 9.5% 4,918,243 View
Jan 08, 2026 SCHEDULE 13G JANUS HENDERSON GROUP PLC 12.2% 6,307,636 View
Dec 23, 2025 SCHEDULE 13D/A — — — View
Dec 11, 2025 SCHEDULE 13G/A Coastlands Capital LP 9.99% 4,886,722 View
Dec 11, 2025 SCHEDULE 13G/A Coastlands Capital Partners LP 9.99% 4,886,722 View
Dec 11, 2025 SCHEDULE 13G/A Coastlands Capital GP LLC 9.99% 4,886,722 View
Dec 11, 2025 SCHEDULE 13G/A Coastlands Capital LLC 9.99% 4,886,722 View
Dec 11, 2025 SCHEDULE 13G/A Matthew D. Perry 9.99% 4,886,722 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.